欧林生物(688319.SH)发行H股备案申请材料获中国证监会接收

Core Viewpoint - The company, Olin Bio (688319.SH), has submitted an application for the public issuance of H-shares and listing on the Hong Kong Stock Exchange, indicating a strategic move to expand its capital base and market presence [1] Group 1 - The company submitted its application to the Hong Kong Stock Exchange on November 25, 2025 [1] - The application materials for the issuance and listing have been published on the Hong Kong Stock Exchange's website on the same day [1] - The company has reported the filing application materials to the China Securities Regulatory Commission (CSRC), which has recently accepted the application [1]